Search
for
Sort by
Research 841–870 of 1000+
- Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
- The endocrinology of baldness
- Organizational Effects of Estrogens and Androgens on Estrogen and Androgen Receptor Expression in Pituitary and Adrenal Glands in Adult Male and Female Rats
- Iatrogenic androgenetic alopecia in a male phenotype 46XX true hermaphrodite
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Generalised Glucocorticoid Resistance
- Registrars’ Symposium: Summaries of Papers
- Endocrine Aspects of Female Sexual Dysfunction
- The inflammatory component of androgenetic alopecia
- Polycystic Ovary Syndrome
- Changes in Hair: Causative Factors
- Antiandrogen Therapy for Skin and Hair Disease
- The diagnosis of androgenetic alopecia in children: Considerations of pathophysiological plausibility
- Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
- Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- Synthesis of mimics of steroid A ring as potential enzyme inhibitors
- Nonscarring alopecias
- Unwanted hair.
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- Cosmeceutical Treatments for Androgenetic Alopecia
- CLINICAL UPDATES IN HAIR
- Андрогенный статус у пациентов с андрогенетической алопецией
- The skin as an endocrine organ
- Nonclassic adrenal hyperplasia
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study
- Recommendations of endocrine treatment for patients with gender dysphoria